A share price of IRIDEX Corp [IRIX] is currently trading at $1.14, down -0.87%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The IRIX shares have gain 3.64% over the last week, with a monthly amount glided 22.58%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On January 26, 2016, Singular Research initiated with a Buy rating and assigned a price target of $11.50 on the stock. First Albany started tracking the stock assigning a Buy rating and suggested a price target of $15.50 on January 03, 2007.
IRIDEX Corp experienced fluctuations in its stock price throughout the past year between $0.78 and $1.87. IRIDEX Corp [NASDAQ: IRIX] shares were valued at $1.14 at the most recent close of the market.
Analyzing the IRIX fundamentals
Trailing Twelve Months sales for IRIDEX Corp [NASDAQ:IRIX] were 50.65M which represents 7.80% growth. Gross Profit Margin for this corporation currently stands at 0.39% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.11%, and Net Profit Margin reading is -0.11%. To continue investigating profitability, this company’s Return on Assets is posted at -0.17, Equity is -1.87 and Total Capital is -0.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.84.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1183 points at the first support level, and at 1.0967 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1633, and for the 2nd resistance point, it is at 1.1867.
Ratios To Look Out For
To put it in perspective, the Current Ratio for IRIDEX Corp [NASDAQ:IRIX] is 1.94. As well, the Quick Ratio is 1.35, while the Cash Ratio is 0.49. Considering the valuation of this stock, the price to sales ratio is 0.39.
Transactions by insiders
Recent insider trading involved MOORE WILLIAM M, Director, that happened on Dec 16 ’25 when 2000.0 shares were purchased. Chief Financial Officer, Dizon Romeo R completed a deal on Dec 12 ’25 to buy 2365.0 shares. Meanwhile, Chief Financial Officer Dizon Romeo R bought 1584.0 shares on Dec 02 ’25.
